Jana Urbanová

Jana Urbanová

Auto-generated profile, based on publicly available information

Jana Urbanová

Third Faculty of Medicine of Faculty Hospital Královské Vinohrady, Charles University, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
IPIuliia Pavlovska
Iuliia Pavlovska
ABAnna Bartošková
Anna Bartošková
JMJeffrey I mechanick
Jeffrey I mechanick
JBJan Broz
Jan Broz
MIMaria Infante
Maria Infante
JRJuan Pablo Gonzalez Rivas
Juan Pablo Gonzalez Rivas
In contrast to the decreasing burden related to cardiovascular disease (CVD), the burden related to dysglycemia and adiposity complications is increasing in Czechia, and local drivers must be identified. A comprehensive literature review was performed to evaluate biological, behavioral, and environmental drivers of dysglycemia and abnormal adiposity in Czechia. Additionally, the structure of the Czech healthcare system was described. The prevalence of obesity in men and diabetes in both sexes has been increasing over the past 30 years. Possible reasons include the Eastern European eating pattern, high prevalence of physical inactivity and health illiteracy, education, and income-related health inequalities. Despite the advanced healthcare system based on the compulsory insurance model with free-for-service healthcare and a wide range of health-promoting initiatives, more effective strategies to tackle the adiposity/dysglycemia are needed. In conclusion, the disease burden related to dysglycemia and adiposity in Czechia remains high but is not translated into greater CVD. This discordant relationship likely depends more on other factors, such as improvements in dyslipidemia and hypertension control. A reconceptualization of abnormal adiposity and dysglycemia into a more actionable cardiometabolic-based chronic disease model is needed to improve the approach to these conditions. This review can serve as a platform to investigate causal mechanisms and secure effective management of cardiometabolic-based chronic disease.

3 June 2020 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
JUJana Urbanová
Jana Urbanová
LBLudmila Brunerová
Ludmila Brunerová
MNMarisa Nunes
Marisa Nunes
JBJan Broz
Jan Broz

28 April 2023 in JMIR Formative Research
Verified
Journal Article
Open access
MVMartina Vlasakova
Martina Vlasakova
JMJan Muzik
Jan Muzik
AHAnna Holubová
Anna Holubová
DFDominik Fiala
Dominik Fiala
EÅEirik Årsand
Eirik Årsand
JBJan Broz
Jan Broz
Background: Today’s diabetes-oriented telemedicine systems can gather and analyze many parameters like blood glucose levels, carbohydrate intake, insulin doses, and physical activity levels (steps). Information collected can be presented to patients in a variety of graphical outputs. Despite the availability of several technical means, a large percentage of patients do not reach the goals established in their diabetes treatment. Objective: The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of patients with type 1 diabetes mellitus. Methods: Data were collected during a 24-week feasibility study. Patients responded to the World Health Organization Quality of Life – BREF (WHOQOL-BREF) questionnaire and a system evaluation questionnaire. The level of glycated hemoglobin (HbA1c) and the patient’s body weight were measured, and the patient’s use of the telemedicine system and their daily physical activity level were monitored. All data were sent from the patient’s device to the Diani server using a real-time diabetes diary app. Wilcoxon and Friedman tests and the linear mixed effects method were used for data analysis. Results: This study involved 10 patients (men: n=5; women: n=5), with a mean age of 47.7 (SD 19.3) years, a mean duration of diabetes of 10.5 (SD 8.6) years, and a mean HbA1c value of 59.5 (SD 6.7) mmol/mol. The median number of days the patients used the system was 84. After the intervention, the mean HbA1c decreased by 4.35 mmol/mol (P=.01). The patients spent 18.6 (SD 6.8) minutes on average using the app daily. After the intervention, the number of patients who measured their blood glucose level at least 3 times a day increased by 30%. The graphical visualization of the monitored parameters, automatic transmission of measured data from the glucometer, compatibility, and interconnection of individual devices when entering data were positively evaluated by patients. Conclusions: The Diani system was found to be beneficial for patients with type 1 diabetes mellitus in terms of managing their disease. Patients perceived it positively; it strengthened their knowledge of diabetes and their understanding of the influences of the measured values on the management of their disease. Its use had a positive effect on the HbA1c level.

21 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJan Broz
Jan Broz
MCMatthew D. Campbell
Matthew D. Campbell
JUJana Urbanová
Jana Urbanová
MNMarisa Nunes
Marisa Nunes
LBLudmila Brunerová
Ludmila Brunerová
JPJan Polák
Jan Polák
The glycemic response to ingested glucose for the treatment of hypoglycemia following exercise in type 1 diabetes patients has never been studied. Therefore, we aimed to characterize glucose dynamics during a standardized bout of hypoglycemia-inducing exercise and the subsequent hypoglycemia treatment with the oral ingestion of glucose. Ten male patients with type 1 diabetes performed a standardized bout of cycling exercise using an electrically braked ergometer at a target heart rate (THR) of 50% of the individual heart rate reserve, determined using the Karvonen equation. Exercise was terminated when hypoglycemia was reached, followed by immediate hypoglycemia treatment with the oral ingestion of 20 g of glucose. Arterialized blood glucose (ABG) levels were monitored at 5 min intervals during exercise and for 60 min during recovery. During exercise, ABG decreased at a mean rate of 0.11 ± 0.03 mmol/L·min−1 (minimum: 0.07, maximum: 0.17 mmol/L·min−1). During recovery, ABG increased at a mean rate of 0.13 ± 0.05 mmol/L·min−1 (minimum: 0.06, maximum: 0.19 mmol/L·min−1). Moreover, 20 g of glucose maintained recovery from hypoglycemia throughout the 60 min postexercise observation window.

1 January 2020
Verified
Journal Article
Closed access
JUJ. Urbanova
J. Urbanova
LBL. Brunerova
L. Brunerova
MNM. A. Nunes
M. A. Nunes
JBJan Broz
Jan Broz

6 April 2022 in Canadian Journal of Diabetes
Verified
Journal Article
Closed access
JUJana Urbanová
Jana Urbanová
BFBrian M. Frier
Brian M. Frier
ATArian Taniwall
Arian Taniwall
KBKlára Brožová
Klára Brožová
JMJana Malinovská
Jana Malinovská
JBJan Broz
Jan Broz